Abstract Background Introduction of Bare Metal Stents (BMS) was itself a revolutionary step
in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its …

The technology of percutaneous coronary intervention (PCI) is constantly being refined in
order to overcome the shortcomings of present day technologies. Even though current …

Background Newer-generation drug-eluting stents that combine ultrathin strut metallic
platforms with biodegradable polymers might facilitate vascular healing and improve clinical …

Aims: The purpose of the study was to investigate whether the favourable outcomes of state-
of-the-art PCI in the SYNTAX II trial, demonstrated at one year, were maintained at two-year …

Objectives: The aim of this study was to assess the 3-year safety and efficacy of treating all-
comer patients with 3 contemporary drug-eluting stents (DES). Background: The BIO …

Background: Coronary drug-eluting stent development has introduced new metal alloys,
changes in stent architecture, and bioresorbable polymers. Whether these advancements …

Importance Stenting small-vessel lesions has an increased adverse cardiovascular event
risk. Very thin-strut or ultrathin-strut drug-eluting stents might reduce this risk, but data are …

New-generation drug-eluting stents (DESs) represent the standard of care for patients
undergoing percutaneous coronary intervention (PCI). Recent iterations in DES technology …

Myocardial revascularization represents the most frequently performed therapeutic
intervention worldwide. Current percutaneous and surgical revascularization techniques …

Objectives The aim of this study was to assess 2-year safety and efficacy of the current-
generation thin composite-wire-strut durable-polymer Resolute Onyx zotarolimus-eluting …